Renaturation separation purification method of tissue plasminogen activator mutant
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- CHINA PHARM UNIV
- Publication Date
- 2004-12-22
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1
Abstract
Description
1. Technical field
[0001] The invention belongs to the technical field of separation and purification of recombinant protein of medical biotechnology. 2. Background technology
[0002] Reteplase is a gene recombinant human tissue plasminogen activator mutant expressed in Escherichia coli by site-directed mutagenesis technology. It is a single-chain aglycosylated polypeptide, containing 355 amino acids, and has the 1-3, 176-527 amino acid coding sequence of natural human tissue plasminogen activator (tissue plasminogen activator, t-PA). Reteplase, which only carries the kringle2 domain and protease domain of wild-type t-PA, has become a comparative therapy because of its long half-life of 16-20 minutes, faster and more thorough thrombolysis and less risk of intracranial hemorrhage. Ideal thrombolytic drug.
[0003] Since reteplase contains 10 pairs of disulfide bonds, it forms inclusion bodies when expressed in Escherichia coli, and it is difficult to correctly fold and ref...